• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国国立综合癌症网络(NCCN)中的疗效评估

Outcomes assessment in the NCCN.

作者信息

Weeks J C

机构信息

Center for Outcomes and Policy Research, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.

出版信息

Oncology (Williston Park). 1997 Nov;11(11A):137-40.

PMID:9430183
Abstract

Outcomes assessment has two primary goals: the evaluation of treatments and the evaluation of quality of care. Data on the outcomes associated with specific interventions may provide an empiric basis for guidelines in areas for which no randomized trial data are available. Also, monitoring of patterns of care and outcomes is an essential component of institutional efforts to implement guidelines and to benchmark themselves against regional and national norms. The National Comprehensive Cancer Network (NCCN) has adopted a three-phase approach to its outcomes assessment program. Phase 1, already completed, involved taking a systematic inventory of members' existing institutional data sources. Phase 2, which is currently in progress, entails pooling data from existing outcomes data bases. In particular, tumor registry data from the National Cancer Data Base are being used to examine patterns of care and outcomes in NCCN institutions and to benchmark them against national norms. Phase 3, begun within the past year, involves the creation of a uniform outcomes assessment system for the NCCN.

摘要

疗效评估有两个主要目标

治疗评估和医疗质量评估。与特定干预措施相关的疗效数据可为尚无随机试验数据的领域制定指南提供实证依据。此外,监测医疗模式和疗效是机构实施指南并对照地区和国家规范进行自我评估的重要组成部分。美国国立综合癌症网络(NCCN)对其疗效评估项目采用了三阶段方法。第一阶段已完成,包括对成员现有的机构数据源进行系统清查。第二阶段正在进行,需要整合现有疗效数据库中的数据。特别是,来自国家癌症数据库的肿瘤登记数据正用于检查NCCN机构的医疗模式和疗效,并对照国家规范进行评估。第三阶段于去年启动,涉及为NCCN创建一个统一的疗效评估系统。

相似文献

1
Outcomes assessment in the NCCN.美国国立综合癌症网络(NCCN)中的疗效评估
Oncology (Williston Park). 1997 Nov;11(11A):137-40.
2
Outcomes assessment in the NCCN: 1998 update. National Comprehensive Cancer Network.美国国立综合癌症网络(NCCN)的疗效评估:1998年更新版。美国国立综合癌症网络。
Oncology (Williston Park). 1999 May;13(5A):69-71.
3
Panel discussion. Data needs in cancer.小组讨论。癌症研究中的数据需求。
Oncology (Williston Park). 1998 Nov;12(11A):147-56.
4
Using tumor registry resources in analyzing concordance with guidelines and outcomes.利用肿瘤登记资源分析与指南的一致性及结果。
Oncology (Williston Park). 2000 Nov;14(11A):104-7.
5
NCCN outcomes research database: data collection via the Internet.美国国立综合癌症网络(NCCN)疗效研究数据库:通过互联网进行数据收集。
Oncology (Williston Park). 2000 Nov;14(11A):100-3.
6
Outcomes research studies.
Oncology (Williston Park). 1996 Nov;10(11 Suppl):29-34.
7
Improving breast cancer care through a regional quality collaborative.通过区域质量协作提高乳腺癌护理水平。
Surgery. 2011 Oct;150(4):635-42. doi: 10.1016/j.surg.2011.07.071.
8
The NCI All Ireland Cancer Conference.美国国家癌症研究所全爱尔兰癌症会议。
Oncologist. 1999;4(4):275-277.
9
NCCN Internet-based data system for the conduct of outcomes research.用于开展疗效研究的美国国立综合癌症网络基于互联网的数据系统。
Oncology (Williston Park). 1998 Nov;12(11A):142-6.
10
The role of the hospital registry in achieving outcome benchmarks in cancer care.医院登记处在实现癌症护理结果基准方面的作用。
J Surg Oncol. 2009 Jun 15;99(8):497-9. doi: 10.1002/jso.21186.

引用本文的文献

1
Inflammatory breast cancer management in the national comprehensive cancer network: the disease, recurrence pattern, and outcome.美国国立综合癌症网络中炎性乳腺癌的管理:疾病、复发模式及预后
Clin Breast Cancer. 2015 Feb;15(1):1-7. doi: 10.1016/j.clbc.2014.05.005. Epub 2014 Jun 23.
2
Interinstitutional variation in management decisions for treatment of 4 common types of cancer: A multi-institutional cohort study.4种常见癌症治疗管理决策中的机构间差异:一项多机构队列研究。
Ann Intern Med. 2014 Jul 1;161(1):20-30. doi: 10.7326/M13-2231.
3
Outcomes by tumor subtype and treatment pattern in women with small, node-negative breast cancer: a multi-institutional study.
女性小细胞、淋巴结阴性乳腺癌的肿瘤亚型和治疗模式的结果:一项多机构研究。
J Clin Oncol. 2014 Jul 10;32(20):2142-50. doi: 10.1200/JCO.2013.53.1608. Epub 2014 Jun 2.
4
Time to adjuvant chemotherapy for breast cancer in National Comprehensive Cancer Network institutions.国家综合癌症网络机构中乳腺癌辅助化疗的时间。
J Natl Cancer Inst. 2013 Jan 16;105(2):104-12. doi: 10.1093/jnci/djs506. Epub 2012 Dec 21.
5
Time to diagnosis and breast cancer stage by race/ethnicity.按种族/民族划分的诊断时间和乳腺癌分期。
Breast Cancer Res Treat. 2012 Dec;136(3):813-21. doi: 10.1007/s10549-012-2304-1. Epub 2012 Oct 26.
6
Impact of hormone receptor status on patterns of recurrence and clinical outcomes among patients with human epidermal growth factor-2-positive breast cancer in the National Comprehensive Cancer Network: a prospective cohort study.激素受体状态对美国国立综合癌症网络中人类表皮生长因子-2阳性乳腺癌患者复发模式和临床结局的影响:一项前瞻性队列研究。
Breast Cancer Res. 2012 Oct 1;14(5):R129. doi: 10.1186/bcr3324.
7
Use of adjuvant trastuzumab in women with human epidermal growth factor receptor 2 (HER2)-positive breast cancer by race/ethnicity and education within the National Comprehensive Cancer Network.美国国家综合癌症网络中基于种族/民族和教育程度,曲妥珠单抗在人表皮生长因子受体 2(HER2)阳性乳腺癌女性中的辅助应用。
Cancer. 2013 Feb 15;119(4):839-46. doi: 10.1002/cncr.27831. Epub 2012 Sep 25.
8
Adoption of gene expression profile testing and association with use of chemotherapy among women with breast cancer.采用基因表达谱检测与乳腺癌女性化疗应用的关联。
J Clin Oncol. 2012 Jun 20;30(18):2218-26. doi: 10.1200/JCO.2011.38.5740. Epub 2012 May 14.
9
The effect of age on delay in diagnosis and stage of breast cancer.年龄对乳腺癌诊断延迟和分期的影响。
Oncologist. 2012;17(6):775-82. doi: 10.1634/theoncologist.2011-0469. Epub 2012 May 3.
10
Institutional variation in the surgical treatment of breast cancer: a study of the NCCN.医疗机构之间治疗乳腺癌方式的差异:NCCN 的研究
Ann Surg. 2011 Aug;254(2):339-45. doi: 10.1097/SLA.0b013e3182263bb0.